These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25453960)

  • 1. Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer.
    Cho EJ; Sun B; Doh KO; Wilson EM; Torregrosa-Allen S; Elzey BD; Yeo Y
    Biomaterials; 2015 Jan; 37():312-9. PubMed ID: 25453960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors.
    Bajaj G; Kim MR; Mohammed SI; Yeo Y
    J Control Release; 2012 Mar; 158(3):386-92. PubMed ID: 22178261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals.
    Sun B; Taha MS; Ramsey B; Torregrosa-Allen S; Elzey BD; Yeo Y
    J Control Release; 2016 Aug; 235():91-98. PubMed ID: 27238443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive hybrid gel improves intraperitoneal platinum delivery.
    Cho S; Sun Y; Jarboe EA; Soisson AP; Dodson MK; Gaffney DK; Peterson CM; Janát-Amsbury MM
    Int J Pharm; 2013 Dec; 458(1):148-55. PubMed ID: 24157346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of platinum-taxane combination therapy in ovarian cancer.
    Desale SS; Soni KS; Romanova S; Cohen SM; Bronich TK
    J Control Release; 2015 Dec; 220(Pt B):651-9. PubMed ID: 26381902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44-targeted microparticles for delivery of cisplatin to peritoneal metastases.
    Li SD; Howell SB
    Mol Pharm; 2010 Feb; 7(1):280-90. PubMed ID: 19994852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma.
    Mukherjee S; Kotcherlakota R; Haque S; Bhattacharya D; Kumar JM; Chakravarty S; Patra CR
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110375. PubMed ID: 31924026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
    Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
    Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect.
    Fan X; Zhao X; Qu X; Fang J
    Int J Pharm; 2015 Dec; 496(2):644-53. PubMed ID: 26529576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels.
    Zahedi P; Stewart J; De Souza R; Piquette-Miller M; Allen C
    J Control Release; 2012 Mar; 158(3):379-85. PubMed ID: 22154933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity.
    Bae KH; Tan S; Yamashita A; Ang WX; Gao SJ; Wang S; Chung JE; Kurisawa M
    Biomaterials; 2017 Dec; 148():41-53. PubMed ID: 28961534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer.
    Emoto S; Yamaguchi H; Kamei T; Ishigami H; Suhara T; Suzuki Y; Ito T; Kitayama J; Watanabe T
    Surg Today; 2014 May; 44(5):919-26. PubMed ID: 23887848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts.
    De Stefano I; Battaglia A; Zannoni GF; Prisco MG; Fattorossi A; Travaglia D; Baroni S; Renier D; Scambia G; Ferlini C; Gallo D
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):107-16. PubMed ID: 20848284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal Delivery of Cisplatin via a Hyaluronan-Based Nanogel/in Situ Cross-Linkable Hydrogel Hybrid System for Peritoneal Dissemination of Gastric Cancer.
    Ohta S; Hiramoto S; Amano Y; Emoto S; Yamaguchi H; Ishigami H; Kitayama J; Ito T
    Mol Pharm; 2017 Sep; 14(9):3105-3113. PubMed ID: 28806513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticles.
    Wang X; Yang C; Zhang Y; Zhen X; Wu W; Jiang X
    Biomaterials; 2014 Aug; 35(24):6439-53. PubMed ID: 24811257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel.
    Yang Y; Wang J; Zhang X; Lu W; Zhang Q
    J Control Release; 2009 Apr; 135(2):175-82. PubMed ID: 19331864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Layer-by-layer nanoparticle platform for cancer active targeting.
    Suh MS; Shen J; Kuhn LT; Burgess DJ
    Int J Pharm; 2017 Jan; 517(1-2):58-66. PubMed ID: 27923697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
    Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
    J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.